Tomaralimab

Tax included
Tomaralimab (OPN-305) is a humanised anti-TLR2 IgG4 monoclonal antibody. Tomaralimab has the potential for the research of Myelodysplastic Syndromes (MDS).
HY-P99555

Data sheet

Size
Multiple sizes
Reactivity
Toll-like Receptor (TLR)
CAS
1449294-76-1